18 and older, any sex, with Amputation; Traumatic, Hand. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
VAL-1: System Comfort Validation TestPrimary· Day 1 (8 hours)
User wears Point Digit(s) for a full day (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall be comfortable for a full day's use. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then, each participant attempted the validation test.
Group
Value
95% CI
Prosthesis
100
VAL-2: Unilateral Function Validation TestPrimary· Day 1 (10 minutes)
User flexes and extends the Point Digit(s) without using contralateral hand (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall allow the user to flex and extend finger without their second hand. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket
Group
Value
95% CI
Prosthesis
100
VAL-3.1: System Robustness Validation Test With 25 lb BagPrimary· Day 1 (10 minutes)
User lifts a 25 lb. bag with Point Digit(s) (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall be robust enough to operate in challenging environments. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then, each participant attempted the vali
Group
Value
95% CI
Prosthesis
100
VAL-3.2: Robustness Validation Test With HammerPrimary· Day 1 (10 minutes)
User grips a hammer with Point Digit(s) and drives a nail into a piece of wood (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall be robust enough to operate in challenging environments. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then,
Group
Value
95% CI
Prosthesis
100
VAL-4: Object Release Validation TestPrimary· Day 1 (10 minutes)
User releases Point Digit(s) while performing an active grasp by pressing the dorsal button (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall be releasable while performing active grasps. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then
Group
Value
95% CI
Prosthesis
100
VAL-5: Position Function Validation TestPrimary· Day 1 (10 minutes)
User positions Point Digit(s) into each of the locking positions (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall have a smooth ratcheting mechanism. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then, each participant attempted the vali
Group
Value
95% CI
Prosthesis
100
VAL-6: Extension Function Validation TestPrimary· Day 1 (10 minutes)
User activates spring-back mechanism by using (1) contralateral hand, (2) tabletop, and (3) side or thigh (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall have a reliable auto spring-back mechanism. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the
Group
Value
95% CI
Prosthesis
100
VAL-7: Grip Functions Validation TestPrimary· Day 1 (10 minutes)
User grips a 5 lb. cylindrical smooth object using Point Digit(s) for 10 seconds (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall have high grip surface friction. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then, each participant attem
Group
Value
95% CI
Prosthesis
100
VAL-8: Fine Motor Function Validation TestPrimary· Day 1 (10 minutes)
User picks up 1 coin from a smooth tabletop (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall have a pronounced fingernail. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then, each participant attempted the validation test.
Group
Value
95% CI
Prosthesis
100
VAL-9: Overall Function & Robustness Validation TestPrimary· Day 1 (8 hours)
User performs VAL-1 through VAL-8 (Pass/Fail). This validation method was used to confirm the following user need of the Point Digit has been met: Point Digit shall be robustly attached to mounting system. A simple pass/fail result was recorded for each user need for each participant. An overall passing rate above 80% across all user needs and participants is considered a success. Each participant attended a single-day experimental session. A day-use prosthetic socket was fabricated and Point Digits were mounted to the socket. Then, each participant attempted the validation test.
Group
Value
95% CI
Prosthesis
100
Sponsor's own description
The objective of the device feasibility study will be to validate the user needs of the Point Digit system. This study will be a single group intervention model where one group of 5 partial hand amputees will be asked to perform several tasks. Successful completion of a task results in a fulfilled user need. Failure to complete a task results in an unfulfilled user need.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT04755790 — To Assess the Utility of the Point Digit in a Clinical Take-home Study
· NA
· completed
Other recruiting trials for Amputation; Traumatic, Hand
Currently open trials in the same condition.
NCT06501092 — To Assess the Utility of the Point Mini in a Clinical Take-home Study
· NA
· recruiting
NCT04725201 — Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization
· Phase 4
· recruiting
Other Point Designs trials
Trials by the same sponsor.
NCT07135947 — To Evaluate the Clinical Impact of the Point Powered System
· NA
· not yet recruiting
NCT06504667 — To Validate Point Mini User Needs
· NA
· withdrawn
NCT06501092 — To Assess the Utility of the Point Mini in a Clinical Take-home Study
· NA
· recruiting
NCT05048394 — Teleoperation Experimental Comparison With Able-bodied Subjects
· NA
· completed
NCT05012683 — To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Point Designs
Last refreshed: 27 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04763278.